Portfolio company
PETDX
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops liquid biopsy blood tests for the early detection of cancer in dogs for use by veterinary professionals.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
DeepScan Diagnostics
This company develops cell-free DNA blood tests for veterinarians to detect cancer and monitor treatment response in dogs.
FidoCure
The company provides genomic testing and AI-enabled personalised treatment recommendations for dogs with cancer to veterinarians and pet owners.
PetMedix
PetMedix develops species-specific monoclonal antibody therapeutics for companion animals to treat chronic and terminal diseases in dogs and cats.
Guardant
The company develops blood-based liquid biopsy tests for cancer screening and monitoring for patients and healthcare providers.
Epiliquid
This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.
Infiniplex
This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.
LEAH Labs
This company develops gene-edited cell therapies for dogs with cancer for use by veterinarians.
AOA Dx
This biotech firm develops non-invasive liquid biopsy tests to provide healthcare providers with early-stage ovarian cancer diagnostics for their patients.